Innovation, resilience – and sympathy

Bill Gates delivers Dimbleby Lecture on polio

20130131_Dimbleby
Bill Gates standing beside an iron lung, “an example of what polio-related innovation looked like” BBC/Guy Levy, The Richard Dimbleby Lecture 2013.

January 31, 2013 – When he was invited to give this year’s prestigious Richard Dimbleby Lecture, Bill Gates could have chosen to speak about a lot of things – from the creation of the personal computer, to life as one of the world’s wealthiest people, to his role as a leading philanthropist. But instead he decided to focus on polio, using the Lecture as a chance to explain why he, along with the foundation he co-founded and the partnership it supports, is so focused on ending this disease:

For Gates, “The fight to eradicate polio stands for what we can do and who we can be. The best of who we are—our capacity for innovation, our resilience, our boundless sympathy for each other—has gotten us to this threshold.”

Gates sees the innovation that polio eradication has catalysed as a model for future efforts to deliver better health to more people. “We are on the verge of doing something we’ve never been able to do before—reaching the vast majority of children in the remotest places in the world. We are building systems, developing technology, and training workers that make it possible to help people who never got any help. When polio is gone, we can use the same systems, technology, and people to deliver other lifesaving solutions, especially routine vaccinations for diseases like rotavirus and measles.”


Related News

   25/10/2022
We are close to making polio the second human disease to be eradicated, but what will it take to finally consign this killer disease to the history books?
   24/10/2022
The Global Polio Eradication Initiative (GPEI) stands tall on the foundation of millions of women’s efforts and voices.
   21/10/2022
Together, we end polio!
   18/10/2022
More than 3000 scientists and health experts from 115 countries urge the world to fully fund eradication strategy following resurgence of disease